Mitsubishi UFJ Morgan Stanley Securities’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$123K Sell
1,100
-680
-38% -$71.7K 0.25% 20
2014
Q3
$169K Buy
1,780
+380
+27% +$34.3K 0.48% 15
2014
Q2
$120K Sell
1,400
-400
-22% -$30.4K 0.35% 19
2014
Q1
$126K Sell
1,800
-600
-25% -$47.5K 0.34% 17
2013
Q4
$203K Buy
2,400
+980
+69% +$77.5K 0.34% 12
2013
Q3
$109K Sell
1,420
-1,780
-56% -$125K 0.18% 18
2013
Q2
$187K Buy
+3,200
New +$193K 0.62% 11

Other funds holding CELG

Mitsubishi UFJ Morgan Stanley Securities's CELG Position: Q4 2014 in Review

Mitsubishi UFJ Morgan Stanley Securities reduced its Celgene Corp (CELG) stake by 38% in Q4 2014, selling an estimated $71.7K and leaving 1,100 shares worth $123K. The position accounts for 0.25% of the portfolio, ranked #20.

Mitsubishi UFJ Morgan Stanley Securities first reported a position in CELG in Q2 2013 and has held it in 7 quarters since. The position peaked at $203K in Q4 2013. 1,161 funds tracked by Wall St. Rank hold CELG as of Q4 2014.

  • Mitsubishi UFJ Morgan Stanley Securities held 1,100 shares of Celgene Corp worth $123K as of Q4 2014.
  • Mitsubishi UFJ Morgan Stanley Securities sold 680 Celgene Corp shares in Q4 2014, an estimated $71.7K.
  • Celgene Corp made up 0.25% of Mitsubishi UFJ Morgan Stanley Securities's portfolio in Q4 2014, its #20 holding.
  • Mitsubishi UFJ Morgan Stanley Securities first reported a position in Celgene Corp in Q2 2013 and has held it in 7 quarters since.
  • Mitsubishi UFJ Morgan Stanley Securities's Celgene Corp position peaked at $203K in Q4 2013.
  • 1,161 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2014.

Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q4 2014, filed 17 Feb 2015.